Comparative effectiveness of oral antibiotics to treat uncomplicated urinary tract infections in male outpatients
Journal of Comparative Effectiveness Research · 2026-04 · 15 (4)
DOI: 10.57264/cer-2025-0163 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Comparative Effectiveness Research, 2026-04. Verfasst von Karl Madaras-Kelly und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Idaho State University, Meridian, ID 83713, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Fluoroquinolones, Urinary Tract Infections, Anti-Infective Agents, Urinary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Aim
New IDSA guidelines define uncomplicated UTI (uUTI) as infection limited to the bladder in both men and women. This study compared the effectiveness of β-lactams, nitrofurantoin and trimethoprim/sulfamethoxazole (TMP/SMX) to fluoroquinolones for outpatient uUTI treatment in men. Materials & methods: A retrospective cohort of adult male outpatients diagnosed with uUTI during 2019–2021 in the Department of Veterans Affairs system was created. Inclusion required an Emergency Department, Urgent/Primary Care visit with ICD-10 documentation of UTI and a prescription of interest dispensed. Patients with recent UTI, hospitalization, infectious co-diagnosis, temperature >99.9 F, pyelonephritis or prostatitis, or for whom asymptomatic bacteriuria treatment was appropriate were excluded. Overlap weighting propensity scores and generalized estimating equation models assessed the relative risk of a subsequent UTI-related visit or hospitalization within 3–30 days with a new antibiotic dispensed.
Results
A total of 45,442 males (mean [SD]) age 71.6 (12.7) years were treated at 130 VA medical centers. Treatment n (%) included: β-lactams 17,655 (38.9%), nitrofurantoin 8394 (18.5%), TMP/SMX 9709 (21.4%) and fluoroquinolones 9684 (21.3%). UTI-related return visits occurred in 5453 (12.0%) and UTI-related hospitalization occurred in 1431 (3.1%). The adjusted relative risk (aRR, [95% CI]) of a return visit compared with fluoroquinolones was higher for β-lactams (1.22, [1.02, 1.48]) and nitrofurantoin (1.47, [1.23, 1.74]) but not for TMP/SMX (0.99, [0.80, 1.23]). The aRR for UTI-related hospitalization was not different for β-lactams (1.06, [0.80, 1.40] or TMP/SMX [0.80, [0.56, 1.15], but was lower for nitrofurantoin [0.60, [0.41, 0.89]).
Conclusion
Compared with fluoroquinolones, β-lactam and nitrofurantoin prescribed for outpatient uUTI were associated with modestly increased UTI-related return visits but not hospitalization in men.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Idaho State University, Meridian, ID 83713, USA.
- Boise VA Medical Center, Boise, ID 83642, USA.
- Department of Biology, Boise State University, Boise, ID 83642, USA.
ORCID-Profile: Karl Madaras-Kelly
Förderung
- NIGMS NIH HHS
Zitieren
APA
Madaras-Kelly, K., Boyd, J., & Bond, L. (2026). Comparative effectiveness of oral antibiotics to treat uncomplicated urinary tract infections in male outpatients. Journal of Comparative Effectiveness Research, 15(4). https://doi.org/10.57264/cer-2025-0163
Vancouver
Madaras-Kelly K, Boyd J, Bond L. Comparative effectiveness of oral antibiotics to treat uncomplicated urinary tract infections in male outpatients. Journal of Comparative Effectiveness Research. 2026;15(4). doi:10.57264/cer-2025-0163
BibTeX
@article{MadarasKelly2026,
author = {Madaras-Kelly, Karl and Boyd, Jeremy and Bond, Laura},
title = {Comparative effectiveness of oral antibiotics to treat uncomplicated urinary tract infections in male outpatients},
journal = {Journal of Comparative Effectiveness Research},
year = {2026},
volume = {15},
number = {4},
doi = {10.57264/cer-2025-0163}
}
EUVIMED